Comparison of b-Cell function between overweight/Obese adults and adolescents across the spectrum of glycemia

Melinda E. Chen, Aaditya G. Chandramouli, Robert Considine, Tamara Hannon, Kieren Mather

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

OBJECTIVE Type 2 diabetes is a growing health problem among both adults and adolescents. To better understand the differences in the pathogenesis of diabetes between these groups we examined differences in b-cell function along the spectrum of glucose tolerance RESEARCH DESIGN AND METHODS We evaluated 89 adults and 50 adolescents with normal glucose tolerance (NGT) dysglycemia, or type 2 diabetes. Oral glucose tolerance test results were used for C-peptide and insulin/glucose minimal modeling. Model-derived and direct mea sures of insulin secretion and insulin sensitivity were compared across glycemic stages and between age-groups at each stage. RESULTS In adolescents with dysglycemia, there was marked insulin resistance (insulin sensi tivity index: adolescents, median [interquartile range] 1.8 [1.1–2.4] 3 1024; adults 5.0 [2.3–9.9]; P = 0.01). The nature of b-cell dysfunction across stages of dysglycemia differed between the groups. We observed higher levels of secretion among adoles cents than adults (total insulin secretion: NGT, 143 [103–284] 3 1029/min adolescen vs. 106 [71–127], P = 0.001); adults showed stepwise impairments in static insulin secretion (NGT, 7.5 [4.0–10.3] 3 1029/min; dysglycemia, 5.0 [2.3–9.9]; type 2 di abetes, 0.7 [0.1–2.45]; P = 0.003), whereas adolescents showed diabetes-related impairment in dynamic secretion (NGT, 1,905 [1,630–3,913] 3 1029; dysglycemia 2,703 [1,323–3,637]; type 2 diabetes, 1,189 [269–1,410]; P = 0.001). CONCLUSIONS Adults and adolescents differ in the underlying defects leading to dysglycemia, and in the nature of b-cell dysfunction across stages of dysglycemia. These results may suggest different approaches to diabetes prevention in youths versus adults.

Original languageEnglish (US)
Pages (from-to)318-325
Number of pages8
JournalDiabetes Care
Volume41
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Glucose
Insulin
Type 2 Diabetes Mellitus
Insulin Resistance
C-Peptide
Glucose Tolerance Test
Type 1 Diabetes Mellitus
Age Groups
Health

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Comparison of b-Cell function between overweight/Obese adults and adolescents across the spectrum of glycemia. / Chen, Melinda E.; Chandramouli, Aaditya G.; Considine, Robert; Hannon, Tamara; Mather, Kieren.

In: Diabetes Care, Vol. 41, No. 2, 01.02.2018, p. 318-325.

Research output: Contribution to journalArticle

@article{c721d4ebf09f4c77b0716466d79d7f13,
title = "Comparison of b-Cell function between overweight/Obese adults and adolescents across the spectrum of glycemia",
abstract = "OBJECTIVE Type 2 diabetes is a growing health problem among both adults and adolescents. To better understand the differences in the pathogenesis of diabetes between these groups we examined differences in b-cell function along the spectrum of glucose tolerance RESEARCH DESIGN AND METHODS We evaluated 89 adults and 50 adolescents with normal glucose tolerance (NGT) dysglycemia, or type 2 diabetes. Oral glucose tolerance test results were used for C-peptide and insulin/glucose minimal modeling. Model-derived and direct mea sures of insulin secretion and insulin sensitivity were compared across glycemic stages and between age-groups at each stage. RESULTS In adolescents with dysglycemia, there was marked insulin resistance (insulin sensi tivity index: adolescents, median [interquartile range] 1.8 [1.1–2.4] 3 1024; adults 5.0 [2.3–9.9]; P = 0.01). The nature of b-cell dysfunction across stages of dysglycemia differed between the groups. We observed higher levels of secretion among adoles cents than adults (total insulin secretion: NGT, 143 [103–284] 3 1029/min adolescen vs. 106 [71–127], P = 0.001); adults showed stepwise impairments in static insulin secretion (NGT, 7.5 [4.0–10.3] 3 1029/min; dysglycemia, 5.0 [2.3–9.9]; type 2 di abetes, 0.7 [0.1–2.45]; P = 0.003), whereas adolescents showed diabetes-related impairment in dynamic secretion (NGT, 1,905 [1,630–3,913] 3 1029; dysglycemia 2,703 [1,323–3,637]; type 2 diabetes, 1,189 [269–1,410]; P = 0.001). CONCLUSIONS Adults and adolescents differ in the underlying defects leading to dysglycemia, and in the nature of b-cell dysfunction across stages of dysglycemia. These results may suggest different approaches to diabetes prevention in youths versus adults.",
author = "Chen, {Melinda E.} and Chandramouli, {Aaditya G.} and Robert Considine and Tamara Hannon and Kieren Mather",
year = "2018",
month = "2",
day = "1",
doi = "10.2337/dc17-1373",
language = "English (US)",
volume = "41",
pages = "318--325",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of b-Cell function between overweight/Obese adults and adolescents across the spectrum of glycemia

AU - Chen, Melinda E.

AU - Chandramouli, Aaditya G.

AU - Considine, Robert

AU - Hannon, Tamara

AU - Mather, Kieren

PY - 2018/2/1

Y1 - 2018/2/1

N2 - OBJECTIVE Type 2 diabetes is a growing health problem among both adults and adolescents. To better understand the differences in the pathogenesis of diabetes between these groups we examined differences in b-cell function along the spectrum of glucose tolerance RESEARCH DESIGN AND METHODS We evaluated 89 adults and 50 adolescents with normal glucose tolerance (NGT) dysglycemia, or type 2 diabetes. Oral glucose tolerance test results were used for C-peptide and insulin/glucose minimal modeling. Model-derived and direct mea sures of insulin secretion and insulin sensitivity were compared across glycemic stages and between age-groups at each stage. RESULTS In adolescents with dysglycemia, there was marked insulin resistance (insulin sensi tivity index: adolescents, median [interquartile range] 1.8 [1.1–2.4] 3 1024; adults 5.0 [2.3–9.9]; P = 0.01). The nature of b-cell dysfunction across stages of dysglycemia differed between the groups. We observed higher levels of secretion among adoles cents than adults (total insulin secretion: NGT, 143 [103–284] 3 1029/min adolescen vs. 106 [71–127], P = 0.001); adults showed stepwise impairments in static insulin secretion (NGT, 7.5 [4.0–10.3] 3 1029/min; dysglycemia, 5.0 [2.3–9.9]; type 2 di abetes, 0.7 [0.1–2.45]; P = 0.003), whereas adolescents showed diabetes-related impairment in dynamic secretion (NGT, 1,905 [1,630–3,913] 3 1029; dysglycemia 2,703 [1,323–3,637]; type 2 diabetes, 1,189 [269–1,410]; P = 0.001). CONCLUSIONS Adults and adolescents differ in the underlying defects leading to dysglycemia, and in the nature of b-cell dysfunction across stages of dysglycemia. These results may suggest different approaches to diabetes prevention in youths versus adults.

AB - OBJECTIVE Type 2 diabetes is a growing health problem among both adults and adolescents. To better understand the differences in the pathogenesis of diabetes between these groups we examined differences in b-cell function along the spectrum of glucose tolerance RESEARCH DESIGN AND METHODS We evaluated 89 adults and 50 adolescents with normal glucose tolerance (NGT) dysglycemia, or type 2 diabetes. Oral glucose tolerance test results were used for C-peptide and insulin/glucose minimal modeling. Model-derived and direct mea sures of insulin secretion and insulin sensitivity were compared across glycemic stages and between age-groups at each stage. RESULTS In adolescents with dysglycemia, there was marked insulin resistance (insulin sensi tivity index: adolescents, median [interquartile range] 1.8 [1.1–2.4] 3 1024; adults 5.0 [2.3–9.9]; P = 0.01). The nature of b-cell dysfunction across stages of dysglycemia differed between the groups. We observed higher levels of secretion among adoles cents than adults (total insulin secretion: NGT, 143 [103–284] 3 1029/min adolescen vs. 106 [71–127], P = 0.001); adults showed stepwise impairments in static insulin secretion (NGT, 7.5 [4.0–10.3] 3 1029/min; dysglycemia, 5.0 [2.3–9.9]; type 2 di abetes, 0.7 [0.1–2.45]; P = 0.003), whereas adolescents showed diabetes-related impairment in dynamic secretion (NGT, 1,905 [1,630–3,913] 3 1029; dysglycemia 2,703 [1,323–3,637]; type 2 diabetes, 1,189 [269–1,410]; P = 0.001). CONCLUSIONS Adults and adolescents differ in the underlying defects leading to dysglycemia, and in the nature of b-cell dysfunction across stages of dysglycemia. These results may suggest different approaches to diabetes prevention in youths versus adults.

UR - http://www.scopus.com/inward/record.url?scp=85041179088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041179088&partnerID=8YFLogxK

U2 - 10.2337/dc17-1373

DO - 10.2337/dc17-1373

M3 - Article

C2 - 29183909

AN - SCOPUS:85041179088

VL - 41

SP - 318

EP - 325

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 2

ER -